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Role of MCP-1 and CCR2 in ethanol-induced
neuroinflammation and neurodegeneration
in the developing brain
Kai Zhang, Haiping Wang, Mei Xu, Jacqueline A. Frank and Jia Luo*

Abstract
Background: Neuroinflammation and microglial activation have been implicated in both alcohol use disorders
(AUD) and fetal alcohol spectrum disorders (FASD). Chemokine monocyte chemoattractant protein 1 (MCP-1) and
its receptor C-C chemokine receptor type 2 (CCR2) are critical mediators of neuroinflammation and microglial
activation. FASD is the leading cause of mental retardation, and one of the most devastating outcomes of FASD is
the loss of neurons in the central nervous system (CNS). The underlying molecular mechanisms, however, remain
unclear. We hypothesize that MCP-1/CCR2 signaling mediates ethanol-induced neuroinflammation and microglial
activation, which exacerbates neurodegeneration in the developing brain.
Methods: C57BL/6 mice and mice deficient of MCP-1 (MCP-1−/−) and CCR2 (CCR2−/−) were exposed to ethanol on
postnatal day 4 (PD4). Neuroinflammation, and microglial activation, and neurodegeneration in the brain were evaluated
by immunohistochemistry and immunoblotting. A neuronal and microglial co-culture system was used to evaluate the
role of microglia and MCP-1/CCR2 signaling in ethanol-induced neurodegeneration. Specific inhibitors were employed to
delineate the involved signaling pathways.
Results: Ethanol-induced microglial activation, neuroinflammation, and a drastic increase in the mRNA and protein levels
of MCP-1. Treatment of Bindarit (MCP-1 synthesis inhibitor) and RS504393 (CCR2 antagonist) significantly reduced ethanolinduced microglia activation/neuroinflammation, and neuroapoptosis in the developing brain. MCP-1−/− and CCR2−/−
mice were more resistant to ethanol-induced neuroapoptosis. Moreover, ethanol plus MCP-1 caused more neuronal
death in a neuron/microglia co-culture system than neuronal culture alone, and Bindarit and RS504393 attenuated
ethanol-induced neuronal death in the co-culture system. Ethanol activated TLR4 and GSK3β, two key mediators of
microglial activation in the brain and cultured microglial cells (SIM-A9). Blocking MCP-1/CCR2 signaling attenuated
ethanol-induced activation of TLR4 and GSK3β.
Conclusion: MCP-1/CCR2 signaling played an important role in ethanol-induced microglial activation/neuroinflammation
and neurodegeneration in the developing brain. The effects may be mediated by the interaction among MCP-1/CCR2
signaling, TLR4, and GSK3β.
Keywords: Alcohol abuse, Apoptosis, Chemokines, Development, Glia, Neurodegeneration
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Background
Fetal alcohol spectrum disorders (FASD) are a spectrum
of defects that can present as physical, mental, and\or
behavioral disabilities that stem from ethanol exposure
during fetal development. FASD is estimated to affect as
many as 2–5% of the population and costs the USA
more than $5 billion annually [1]. One of the most
devastating effects of developmental exposure to ethanol
is the permanent loss of neurons in the central nervous
system (CNS) [2, 3]. Although significant progress has
been achieved in this line of research, the underlying
molecular mechanisms remain unclear. Ethanol-induced
neuronal death is accompanied by microglial activation
and neuroinflammation [4–7]. Monocyte chemoattractant protein 1 (MCP-1), also called chemokine (CC
motif ) ligand 2 (CCL2), is a key chemokine involved in
neuroinflammation [8–10]. In mouse and human brain,
MCP-1 and its receptor CCR2 are primarily expressed
by microglia [8]. Although inflammatory response represents one of the first immune processes that protect an
organism against diseases following injury, prolonged
and sustained inflammation may have cytotoxic effects,
aggravating the incidence and the severity of the disease.
Increased MCP-1 expression and microglial activation
have been observed in the brain of human alcoholics
[11]. It has been hypothesized that ethanol exposure
may sensitize the immune system to subsequent insults
and lead to excess neuroinflammation in alcohol use disorders (AUD) and FASD [12, 13]. It is also proposed that
microglia primed by ethanol exposure may contribute to
neurotoxicity observed in AUD and FASD [12, 13]. Elevated MCP-1 levels have been observed in brains which
undergo various pathogenesis processes, such as multiple sclerosis [14, 15], stroke [16, 17], and Alzheimer’s
disease patients [18, 19], and it is believed that the upregulation of MCP-1 is involved in the progression of
these diseases [15, 16, 19]. Interestingly, the detrimental
effects caused by overexpression of MCP-1 in those diseases were not observed in mice lacking CCR2 [20–23].
Therefore, MCP-1/CCR2 signaling may play an important role in neuroinflammatory diseases. In this study, we
sought to determine whether MCP-1/CCR2 signaling is
involved in ethanol-induced microglial activation and
neuroinflammation in the context of neurodegeneration
in the developing brain. We used a well-established third
trimester equivalent mouse model in which ethanol
exposure caused wide spread neurodegeneration. We
showed that inhibiting MCP-1/CCR2 signaling significantly reduced ethanol-induced microglial activation/neuroinflammation and ameliorated neurodegeneration in the
developing brain. It appeared that ethanol-induced
microglial activation/neuroinflammation was mediated by
the interaction among MCP-1/CCR2 signaling, TLR4, and
GSK3β.
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Methods
Reagents

Bindarit, an inhibitor of MCP-1 synthesis, was purchased
from Cayman chemical (Ann Arbor, MI, USA). CCR2
antagonist RS504393 was purchased from TOCRIS, Inc.
(Minneapolis, MN, USA). TLR4 inhibitor TAK242 was
purchased from EMD Millipore, Inc. (Burlington, MA,
USA). GSK3β inhibitor SB-216763 was purchased from
Sigma-Aldrich, Inc. (St. Louis, MO, USA). Anti-MCP-1
antibody was purchased from Bio-Rad AbD Serotec, Inc.
(Raleigh, NC, USA). Anti-CCR-2 antibody was purchased from BioVision, Inc. (Milpitas, CA, USA).
Anti-Iba-1 antibody was purchased from Wako Chemicals USA, Inc. (Richmond, VA, USA). All other antibodies were purchased from Cell Signaling Technology,
Inc. (Beverly, MA, USA). Other chemicals/reagents used
in this project were obtained from Thermo Fisher Scientific, Inc. (Waltham, MA, USA) unless stated otherwise.
Animals and ethanol exposure

C57BL/6J mice were obtained from Jackson Laboratory
(Bar Harbor, ME, USA). C57BL/6 mice, MCP-1−/−
(B6.129S4-Ccl2tm1Rol/J), and CCR2−/− (B6.129S4-Ccr2tm1Ifc/J)
mice were obtained from Jackson Laboratories (Bar Harbor,
ME, USA). All animals were housed in a specific
pathogen-free room within the animal facilities at the
University of Kentucky, and handled according to the Institutional Animal Care and Use Committee (protocol #:
2008-0401).
Postnatal day 4 (PD4) mouse pups of either sex from
six litters were weighed, and randomly assigned to one
of six groups: control, ethanol (EtOH), Bindarit,
RS504393, EtOH plus Bindarit, and EtOH plus
RS504393. Pups received a total of 5 g/kg ethanol in two
subcutaneous (SC) injections which were 2 h apart; each
contained ethanol (2.5 g/kg, 20% solution in saline) [24,
25]. We have previously determined that the blood alcohol concentration (BAC) was 338 mg/dl 8 h after the
first injection [25]. BACs greater than 300 mg/dl are not
uncommon in human alcoholics [26–29]. Some alcoholics with a BAC > 400 mg/dl were coherent and able
to drive [29]. BACs> 500 mg/dl have been reported in
heavy drinkers [27, 28, 30]. Bindarit is an inhibitor of
MCP-1 synthesis and RS504393 is an antagonist for
CCR2; they have been extensively used to block MCP-1/
CCR2 signaling in vitro and in vivo [31, 32]. Bindarit
(100 mg/kg) or RS504393 (1 mg/kg) were administered
by two subcutaneous (SC) injections at 24 and 0.5 h
prior to ethanol exposure. The concentrations of
Bindarit and RS504393 used in this study were based on
previous publications [31, 32]. The control pups received
an injection of equal volume of saline or DMSO, depending on whether it was an inhibitor or ethanol exposure. At 8 h after the first ethanol injection, pups were
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sacrificed and the brains were dissected and processed for
further analysis. A diagram showing the paradigm of ethanol and inhibitor administration is demonstrated (Fig. 1).
Culture of microglial cells and neurons

Immortalized mouse microglia cells (SIM-A9) were purchased from American Type Culture Collection (ATCC)
(Manassas, VA, USA). SIM-A9 cells are a spontaneously
immortalized microglial cell line that exhibits key characteristics of cultured primary microglia [33]. SIM-A9
cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM)/F12 medium supplemented with 5%
horse serum, 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin
at 37 °C in 5% CO2 in a humidified atmosphere. The
culture medium was replaced with DMEM/F12 medium
without FBS at 50–60% confluence overnight before indicated treatment. The cultures were exposed to ethanol
(0.2, 0.4, or 0.8%) in sealed containers. The containers
were placed in a humidified environment and maintained at 37 °C with 5% CO2. Using this method, the
ethanol concentration in the culture medium can be accurately maintained [34]. To block MCP-1/CCR2 signaling, SIM-A9 cells were exposed to Bindarit (300 μM) or
RS504393 (100 μM) for 12 h prior to ethanol treatment.
The concentrations of Bindarit and RS504393 were
based on previous publications [35, 36]. To block TLR4
or GSK3β signaling, SIM-A9 cells were exposed to
TAK242 (1 μM) or SB 216763 (10 μM) for 12 h prior to
ethanol treatment. The concentrations of TAK242 and
SB 216763 were based on previous studies [37, 38]. Primary cortical and cerebellar neurons were generated
from the brain of C57BL6 mice on postnatal day 1. The
methods for the isolation and culture of primary cortical
and cerebellar neurons have been previously described
in detail [39, 40]. Briefly, the pups were decapitated, and
the brain immediately transferred into dissection
medium (97.5% Hank’s balanced salt solution, 0.11 mg/
ml sodium pyruvate, 0.1% glucose, 10 mM HEPES,
100 U/ml penicillin, and100 μg/ml streptomycin). The
meninges were removed, and the cerebral cortices and
cerebella dissected. Cerebral cortical tissues and cerebella were dissociated with 0.25% trypsin followed by
0.1% DNase treatment. Then, tissues were carefully triturated, and the cell suspension was mixed with 4%

Page 3 of 14

bovine serum albumin and centrifuged. The cell pellet
was resuspended in Neurobasal/B27 medium containing
B27 (2%), glutamine (1 mM/L), penicillin (100 U/ml),
and streptomycin (100 μg/ml). Cells were plated onto
poly-D-lysine (50 μg/ml)-coated cell culture plates. The
co-cultures of microglia cells and primary cortical neurons or cerebellar neurons were established in 24-well
cell culture plates with inserts as described previously
[41]. The cortical or cerebellar neurons were maintained
in the cell culture plate containing 500 μl of medium at
a density of 4 × 106 cells/well. SIM-A9 cells were grown
in a Falcon™ Cell Culture Insert (1 μm pore size, Cat#:
C353104) in a separate plate at a density of 1 × 106 cells/
per insert in 200 μl of medium overnight at 37 °C and
5% CO2, then treated with Bindarit (300 μM) or
RS504393 (100 μM) for 12 h. After that, the inserts
containing SIM-A9 cells were placed into the wells
containing the cortical neurons or cerebellar neurons.
The co-cultures were then treated with ethanol for 48 h.
The viability of neurons was determined by a
3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay as previously described [40].
Immunoblotting

After treatment, mice were anesthetized by intraperitoneal
injection of ketamine/xylazine, and the cerebral cortices
and cerebella were immediately dissected. The tissue was
frozen in liquid nitrogen and stored at − 80 °C. The protein from brain tissue or SIM-A9 cells were extracted and
processed for immunoblotting (IB) as previously described
[40]. Briefly, tissues or cells were homogenized in an ice
cold lysis buffer containing 50 mM Tris–HCl (pH 7.5),
150 mM NaCl, 1 mM EGTA, 0.5% NP-40, 0.25% SDS,
1 mM PMSF, 5 μg/ml leupeptin, and 5 μg/ml aprotinin.
Homogenates were centrifuged at 20,000 g for 30 min at
4 °C, and the supernatant fraction was collected. Aliquots
of the protein samples were separated on a SDS-polyacrylamide gel by electrophoresis. The separated proteins were
transferred to nitrocellulose membranes. The membranes
were probed with primary antibodies overnight at 4 °C.
The immune complexes were detected by the enhanced
chemiluminescence substrate (GE Healthcare, Chalfont,
Buckinghamshire, UK). The density of immunoblotting
was quantified with the software of Image lab 5.2 (Bio-Rad
Laboratories, Hercules, CA, USA).

Fig. 1 Paradigm for ethanol and inhibitor administration. Mouse pups received two subcutaneous (SC) injections of ethanol which were 2 h apart;
each contained ethanol (2.5 g/kg, 20% solution in saline). Bindarit (100 mg/kg) or RS504393 (1 mg/kg) was administered by two SC injections at 24
and 0.5 h prior to the first ethanol exposure
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Quantitative real-time RT-PCR

After ethanol treatment, mice were decapitated and the
cortex was quickly frozen in liquid nitrogen and then
stored in − 80 °C until use. Total RNA was isolated using
TRIZOL reagent (Invitrogen) according to the manufacturer’s instructions. 1 μg of total RNA was used for first
strand cDNA synthesis (Promega, A3500). Quantitative
real-time RT-PCR was performed on a Lightcycler 480
system (Roche) using a Power SYBR Green PCR Master
kit (Invitrogen, 4368706) with cDNA and primers (1 μM)
according to the manufacturer’s recommendation. The
primers used for analysis were as follows: CCR2 forward
5′-GGTCATGATCCCTATGTGG-3′. CCR2 reverse 5′-C
TGGGCACCTGATTTAAAGG-3′. MCP-1 forward 5′-C
TTCTGGGCCTGCTGTTCA-3′. MCP-1 Reverse 5′-CA
GCCTACTCATTGGGATCA-3′. After finishing the last
cycle, a melting curve analysis was performed. Standard −ΔΔCt method was used for determining the
gene expression.
Immunohistochemistry and determination of activated
microglia

The procedure for immunohistochemistry (IHC) has
been previously described [42]. Briefly, the pups were
decapitated and the brain tissues were removed, post
fixed in 4% paraformaldehyde for 24 h and then transferred to 30% sucrose in PBS until the brain sunk to the
bottom. Sagittal brain sections (20–40 μm) were cut on
a freezing microtome. Floating sections were permeabilized with 0.1% Triton X-100 in PBS and incubated in
0.3% H2O2/50% methanol in PBS and then mounted on
slides and dried. The slides were blocked with 5%
normal goat serum containing 0.5% Triton X-100 in PBS
at room temperature, and then incubated with primary
antibodies (diluted in PBS with 1% BSA) overnight at 4 °C.
The dilution for the primary antibodies was anti-cleaved
caspase-3 antibody, 1:600; anti-Iba1 antibody, 1:600. After
washing with PBS, slides were incubated with a
biotin-conjugated goat anti-rabbit secondary antibody
(1:1000) for 1 h at room temperature and then washed
with PBS. Avidin-biotin-peroxidase complex was prepared
according to the manufacturer’s instructions. The slides
were incubated in the complex for 1 h at room
temperature. After rinsing, the slides were developed in
0.05% 3, 3′-diaminobenzidine (DAB) containing 0.003%
H2O2 in PBS.
Iba-1 IHC has been extensively used to identify
microglia. Activated microglia were determined morphologically. The resting microglia exhibit long branching processes and a small cellular body, while the
activated microglia have fewer but thicker processes
with a larger cell body [43]. The average numbers of
activated Iba-1-positive cells and all Iba-1-positive cells
were calculated from three randomly selected
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microscopic fields, and three consecutive sections were
analyzed for each brain.
Fluoro-Jade C staining

Fluoro-Jade C is a sensitive fluorescent marker for degenerating neurons. The procedure for Fluoro-Jade C
staining has been previously described in detail [44].
Briefly, frozen slides of brain tissue were prepared at a
thickness of 10 μm and first immersed in a basic alcohol
solution consisting of 1% sodium hydroxide in 80% ethanol. They were then rinsed in 70% ethanol and
incubated in 0.06% potassium permanganate solution.
Slides were then transferred to a 0.0001% solution of
Fluoro-Jade C (Chemicon, Temecula, CA, USA),
dissolved in 0.1% acetic acid vehicle. The slides were
then rinsed with distilled water. The air-dried slides were
then cleared in xylene for at least 1 min and then cover
slipped with DPX (Sigma) non-fluorescent mounting
media. The slides were examined and recorded with a
fluorescent microscope (IX81, Olympus).

Statistical analysis
The data were presented as mean ± SEM. Statistical
significance was determined by the ANOVA followed by
Tukey’s post hoc test. Differences in which p was < 0.05
were considered statistically significant.
Results
Ethanol increases MCP-1 expression in the developing
brain and cultured microglial cells

Ethanol exposure increases the expression MCP-1 in the
adult brain of mice and human alcoholics [11, 45]. To
evaluate the role of MCP-1/CCR2 in ethanol-induced
damage in the developing brain, we first sought to determine the effect of ethanol on MCP-1/CCR2 expression
in the developing brain. Using a well-established mouse
model of postnatal ethanol exposure [2, 24, 25], we
showed that ethanol increased MCP-1 expression but
not CCR2 in the brain of postnatal day 4 (PD4) mice
(Fig. 2a). Ethanol also upregulated MCPIP, a downstream effector of MCP-1/CCR2 signaling. Consistently,
ethanol increased mRNA levels of MCP-1 but not CCR2
(Fig. 2b). Since microglia are the major source of
MCP-1, we examined the effect of ethanol on a cultured
microglial cell line (SIM-A9). Ethanol drastically increased the expression of MCP-1 but not CCR2 in
SIM-A9 cells (Fig. 2c).
Bindarit and RS504393 block ethanol-induced caspase-3
activation in the developing brain

In this model of postnatal ethanol exposure, ethanol
caused a wide-spread neuroapoptosis in the developing
brain, which was indicated by the expression of cleaved
caspase-3 [2, 24, 25]. As shown in Fig. 3, a significant

Zhang et al. Journal of Neuroinflammation (2018) 15:197

Page 5 of 14

Fig. 2 Effect of ethanol on MCP-1 and CCR2 expression. a C57BL6 mice of postnatal day 4 (PD4) were exposed to ethanol (EtOH) as described in the
“Methods” section. 8 h after EtOH exposure, mice were sacrificed and the brain was processed for immunoblotting (IB) analysis of MCP-1 and CCR2.
The expression of MCP-1, MCPIP, and CCR2 in the brain was quantified and normalized to actin. Each data point was the mean ± SEM of six animals.
b The expression of MCP-1 and CCR2 mRNA in the brain was determined by quantitative RT-PCR as described in the “Methods” section. Each data
point was the mean ± SEM of three animals. ***p < 0.001, statistically significant difference from control group. c SIM-A9 cells were exposed to EtOH
(0.4%) for 3, 6, 12, or 12 h. The expression of MCP-1 and CCR2 was determined by IB and quantified by the normalization to the expression of actin.
Each data point was the mean ± SEM of three independent experiments. *p < 0.05, statistically significant difference from control group

alteration in cleaved caspase-3 was observed in the cortex
[F(5,30) = 59.56; p ≤ 0.05] and cerebellum [F(5,30) = 48.18;
p ≤ 0.05]. Ethanol increased the expression of cleaved
caspase-3 in the cerebral cortex and cerebellum. Bindarit
or RS504393 treatment significantly decreased ethanol-induced caspase-3 activation. There was little caspase-3 activation in the saline-injected controls and in Bindarit- or
RS504393-treated groups.
MCP-1−/− and CCR2−/− mice are more resistant to ethanol
neurotoxicity

To verify the study using MCP-1 and CCR2 inhibitors,
we compared ethanol-induced neuroapoptosis in the
cortex and cerebellum among wild-type (WT), MCP-1−/
−
mice, and CCR2−/− mice. As shown in Fig. 4, ethanol
increased the expression of cleaved caspase-3 in the cortex and cerebellum of WT mice; ethanol also increased
the expression of cleaved caspase-3 in MCP-1−/− mice
and CCR2−/− mice, but to a much lesser extent (Fig. 4a).
It appeared that deletion of MCP-1 was more effective
than CCR2 in terms of protective effects (Fig. 4b). The
results from IB analysis confirmed that MCP-1−/− and
CCR2−/− mice were less affected by ethanol-induced caspase 3 activation (Fig. 4b); F(2,33) = 16.57, p ≤ 0.05 for
the cortex, and F(2,33) = 9.04, p ≤ 0.05, for the

cerebellum. It appeared that CCR2 deletion did not offer
protection in the cerebellum. MCP-1 and CCR2
deficiency-mediated protection against ethanol-induced neurodegeneration was confirmed by a decrease in Fluoro-Jade
C-positive cells in MCP-1−/− and CCR2−/− mice, compared
to WT mice following ethanol exposure (Fig. 4c).
Bindarit and RS504393 alleviate ethanol-induced
proinflammatory cytokines and microglial activation

Ethanol-induced neuronal death is accompanied by neuroinflammation which may play a role in CNS damage.
We sought to determine whether Bindarit or RS504393
can
reduce
ethanol-induced
neuroinflammation.
Interleukin-6 (IL-6) and tumor necrosis factor alpha
(TNFα) are major pro-inflammatory cytokines that are
involved in injuries in the CNS [46, 47]. Ethanol increased the expression of IL-6 and TNFα in the brain of
PD4 mice and cultured SIM-A9 cells; Bindarit and
RS504393 inhibited ethanol-induced increase of IL-6
[F(3,20) = 40.12; p ≤ 0.05], and TNFα [F(3,20) = 31.21;
p ≤ 0.05] in the developing brain (Fig. 5a) and in cultured
SIM-A9 cells [IL6, F(3,8) = 29.31; p ≤ 0.05; TNFα, F(3,8)
= 30.54; p ≤ 0.05] (Fig. 5b). Pathological activation of
microglia is involved in neuroinflammation and neurodegeneration in various CNS disorders [48–51]. We
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Fig. 3 Effect of Bindarit and RS504393 on ethanol-induced apoptotic neuronal death in the developing mouse brain. Bindarit (100 mg/kg) or
RS504393 (1 mg/kg) was administered by two subcutaneous (SC) injections at 24 and 0.5 h prior to EtOH exposure as described in the “Methods”
section. 8 h after EtOH injection, the pups were sacrificed and the brains were harvested. The expression of cleaved caspase-3 in the cerebral
cortex (CTX) and cerebellum (CB) was determined by IB and quantified by the normalization to actin. Each data point was the mean ± SEM of six
animals. *p < 0.05, statistically significant difference from control group; # p < 0.05, statistically significant difference from EtOH-treated group

therefore examined the effect of Bindarit or RS504393 on
ethanol-induced microglia activation. Microglial activation
was assessed morphologically by IHC of Iba-1. Ethanol
significantly increased the number of active microglia;
Bindarit and RS504393 inhibited ethanol-induced activation of microglia [F(5,12) = 200.63; p ≤ 0.05] (Fig. 6).

or cortical neuron cultures [F(6,14) = 32.45, p ≤ 0.05]
alone. Bindarit and RS504393 significantly ameliorated
ethanol-induced neuronal death in the microglia/cerebellar neuron co-cultures [F(6,14) = 28.71, p ≤ 0.05], and
microglia/cortical neuron co-cultures [F(6,14) = 26.19,
p ≤ 0.05] (Fig. 7b).

Bindarit and RS504393 protect neurons against ethanolinduced neuronal death in co-cultures of primary neurons
and microglia cells

TLR4 and GSK3β mediate ethanol-induced
proinflammatory cytokines in microglial cells

Since inhibition of MCP-1/CCR2 signaling alleviated
ethanol-induced neuroapoptosis and microglial activation in the developing brain, we hypothesized that
MCP-1/CCR2-regulated microglial activation may contribute to neuronal death. To test this hypothesis, we
used a co-culture system in which primary neurons
(mouse cortical neurons or cerebellar neurons) and
microglial cells (SIM-A9 cells) were cultured together,
allowing communication without direct contact. As
shown in Fig. 7a, ethanol- and MCP-1-induced neuronal
death was greater in microglia/neuron co-cultures than
in cerebellar neuron cultures [F(6,14) = 34.18, p ≤ 0.05]

It is well established that TLR4 and its downstream
adaptors TRIF and MyD88 regulate microglial activation
and production of inflammatory mediators [52–54].
GSK3β is also a key mediator of microglial activation
and neuroinflammation [55–57]. MCP-1 was shown to
activate GSK3β signaling in human breast carcinoma
cells [58]. We hypothesized that the interaction among
MCP-1/CCR2, TLR4, and GSK3β may mediate
ethanol-induced microglial activation and expression of
proinflammatory factors. We first determined whether
TLR4 and GSK3β were involved in ethanol-induced expression of proinflammatory cytokines. We pre-treated
SIM-A9 cells with either TLR4 inhibitor TAK242 or
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Fig. 4 Effect of ethanol on the developing brain of wild-type, MCP-1−/−, and CCR2−/− mice. Wild-type (WT), MCP-1−/−, and CCR2−/− mice of PD4
were exposed to EtOH for 8 h. a The expression of cleaved caspase-3 in the cerebral cortex (CTX) and the cerebellum (CB) was examined by
immunohistochemistry (IHC) as described in the “Methods” section. Bar = 100 μm. b The expression of cleaved caspase-3 in the CTX and CB was
determined by IB and quantified by the normalization to the expression of actin. Each data point was mean ± SEM of 3–5 animals **p < 0.01, *p < 0.05,
statistically significant difference from WT group. c The degenerating neurons in the visual cortex were demonstrated by Fluoro-Jade C staining as
described in the “Methods” section. Bar = 100 μm

GSK3β inhibitor SB216763 to block TLR4 and GSK3β
signaling prior to ethanol exposure. As shown in Fig. 8,
TAK242 and SB216763 drastically attenuated ethanol-induced increase in the expression of Iba-1 [F(3,8) = 40.13,
p ≤ 0.05], IL-6 [F(3,8) = 56.78, p ≤ 0.05], and TNF-α
[F(3,8) = 65.17, p ≤ 0.05]. We next sought to determine
whether MCP-1/CCR2 signaling was involved in
ethanol-activated GSK3β and TLR4. The activity of
GSK3β is mainly regulated by the phosphorylation at
serine 9 which results in the inhibition of GSK3β [59–61],
conversely, the phosphorylation at tyrosine 216 positively
regulated its activity [62]. As shown in Fig. 9a, ethanol activated GSK3β by reducing the phosphorylation at Ser9 in
SIM-A9 cells; blocking MCP-1/CCR2 signaling by
Bindarit or RS504393 attenuated ethanol-induced dephosphorylation of GSK3β (Ser9) [F(3,8) = 50.87, p ≤ 0.05].
Blocking MCP-1/CCR2 signaling also inhibited ethanolinduced TLR4 (F(3,8) = 35.27; p < 0.05). Animal studies
confirmed these findings and showed that Bindarit or
RS504393 treatment attenuated ethanol-induced dephosphorylation of GSK3β (Ser9) [F(3,8) = 59.54; p ≤ 0.05] and

upregulation of TLR4 [F(3,8) = 52.18; p ≤ 0.05], MyD88
[F(3,8) = 57.15, p ≤ 0.05], and TRIF [F(3,8) = 63.17;
p ≤ 0.05] in the brain of PD4 mice (Fig. 9b).
We then investigated the interaction between TLR4 and
GSK3β in response to ethanol exposure. Inhibition of
TLR4 signaling by TAK242 attenuated ethanol-induced
dephosphorylation of GSK3β (Ser9) [F(3,8) = 19.98;
p ≤ 0.05] and upregulation of MCP-1 [F(3,8) = 56.78;
p ≤ 0.05] in SIM-A9 cells (Fig. 9c). On the other hand,
blocking GSK3β activation by SB216763 inhibited
ethanol-induced increase of MCP-1 [F(3,8) = 70.35;
p ≤ 0.05] and TLR4 [F(3,8) = 42.36; p ≤ 0.05](Fig. 9d).
The results indicated that there was considerable
interaction among MCP-1/CCR2 signaling, TLR4, and
GSK3β in response to ethanol exposure.

Discussion
In this study, we showed that ethanol increased the expression of MCP-1 but not CCR2 in the brain of PD4
mice and microglia cells (SIM-A9). MCP-1 synthesis inhibitor Bindarit and CCR2 antagonist RS504393
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Fig. 5 Effect of Bindarit and RS504393 on ethanol-induced inflammation in the developing brain and SIM-A9 cells. a Bindarit (100 mg/kg) or
RS504393 (1 mg/kg) was administered by two subcutaneous (SC) injections at 24 and 0.5 h prior to EtOH exposure as described in the “Methods”
section. 8 h after EtOH injection, the pups were sacrificed and the brains were harvested. The relative expression for proinflammatory cytokines
IL-6 and TNFα in the brain of PD4 mice were determined with IB and quantified as described above. Each data point was the mean ± SEM of six
animals. *p ≤ 0.05, statistically significant difference from control group; #p ≤ 0.05, statistically significant difference from EtOH-treated group. b SIM-A9
cells were pretreated with Bindarit (300 μM) or RS504393 (100 μM) for 12 h prior to EtOH (0.4%) exposure. After ethanol exposure for 12 h, cells were
harvested and processed for the expression of proinflammatory IL-6 and TNFα by IB as described above. Data are the mean ± SEM of three independent
experiments. *p < 0.05, statistically significant difference from control group; #p < 0.05, statistically significant difference from EtOH-treated group

inhibited ethanol-induced neuroapoptosis, microglial
activation, and the expression of pro-inflammatory
factors. Further studies using gene knock out mice
confirmed that the deficiency in MCP-1 or CCR2 made
mice more resistant to ethanol-induced neurodegeneration.

Moreover, ethanol and MCP-1 caused more neuronal
death in neuron/microglia co-cultures than neuronal
culture alone. Blocking MCP-1/CCR2 signaling protected
primary cortical and cerebellar neurons against
ethanol-induced death in the neuron/microglia

Fig. 6 Effect of Bindarit and RS504393 on ethanol-induced microglial activation in the developing mouse brain. Bindarit (100 mg/kg) or RS504393
(1 mg/kg) was administered by two subcutaneous (SC) injections at 24 and 0.5 h prior to EtOH exposure as described above. 8 h after EtOH injection,
the pups were sacrificed and the brains were harvested. A representative image of inferior colliculus is shown. Microglia were identified by IHC of
Iba-1. The resting microglia exhibit long branching processes and a small cellular body, which are indicated by arrow heads; while the activated
microglia have fewer but thicker processes with a larger cell body, which are indicated by arrows. The percentage of activated Iba-1 positive cells in
total Iba-1 positive cells was calculated as described in the “Methods” section. Bar = 50 μm. Each data point was the mean ± SEM of three animals.
*p < 0.05, statistically significant difference from control group, #p < 0.05, statistically significant difference from EtOH-treated group
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Fig. 7 Effect of Bindarit and RS504393 on ethanol-induced neuronal death in the co-cultures of microglia/primary neurons. a Co-cultures of SIM-A9
cells and primary cortical neurons/cerebellar neurons were established described in the “Methods” section. The co-cultures were treated with MCP-1
(10 ng/ml in PBS) or EtOH (0.4%) for 48 h. The viability of neurons was determined by MTT as described in the “Methods” section. Data were the
mean ± SEM of three independent experiments. *p < 0.05, statistically significant difference from primary neuronal culture alone. b SIM-A9 cells were
treated with Bindarit (300 μM) or RS504393 (100 μM) for 12 h. After that, the inserts containing SIM-A9 cells were placed in the culture wells containing
cortical neurons or cerebellar neurons. The co-cultures were then treated with EtOH (0.4%) for 48 h, and the viability of neurons was determined by
MTT. Each data point was the mean ± SEM of three independent experiments. *p < 0.05, statistically significant difference from co-cultures without
Bindarit or RS504393 treatment

co-cultures. It appeared that TLR4 and GSK3β mediated
ethanol-induced microglial activation and pro-inflammatory
cytokines in cultured microglia cells, and there was
considerable interaction among TLR4, GSK3β, and
MCP-1/CCR2 signaling in response to ethanol exposure.
The mechanisms underlying ethanol-induced neurodegeneration in the developing brain are complex. Multiple
mechanisms may be involved; these include oxidative
stress [63, 64], endoplasmic reticulum (ER) stress [25],
and interference of signaling by neurotrophic factors and
disruption of microRNAs [65]. Recent evidence indicates
that neuroinflammation plays an important role in the
pathogenesis of FASD and AUD [12, 66, 67].

Ethanol-induced neurodegeneration in both adult and
developing brain is accompanied by microglial activation
and neuroinflammation [12, 66, 68, 69]. We have recently shown that inhibition of microglial activation and
neuroinflammation by minocycline offered protection
against ethanol-induced neurodegeneration in the developing brain [41], suggesting that microglial activation
and neuroinflammation may contribute to ethanol
neurotoxicity in the immature CNS.
MCP-1 is a key chemokine involved in neuroinflammation. In mouse and human brain, MCP-1 and its receptor CCR2 are primarily expressed by microglia [8].
MCP-1/CCR2 signaling is involved in numerous

Fig. 8 Role of TLR4 and GSK3β in EtOH-induced inflammation. SIM-A9 cells were pretreated with TAK242 (1 μM) or SB-216763 (10 μM) for 12 h,
then exposed to EtOH (0.4%) for 12 h. The expression of Iba-1, TNFα, and IL-6 was determined by IB and quantified by the normalization to the
expression of actin. Each data point the mean ± SEM of three independent experiments. *p < 0.05, statistically significant difference from control
group; #p < 0.05, statistically significant difference from EtOH-treated group
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Fig. 9 The interaction of MCP-1/CCR2 signaling, TLR4 and GSK3β in response to ethanol exposure. a SIM-A9 cells were pretreated with RS504393
(100 μM) or Bindarit (300 μM) for 12 h, and then exposed to EtOH (0.4%) for 12 h. The expression of GSK3β, phosphorylated GSK3β at serine 9
(phospho-GSK3βS9), phosphorylated GSK3β at tyrosine 216 (phospho-GSK3βY216), and TLR4 were determined by IB and quantified by the normalization
to the expression of actin. b C57BL6 mice of PD4 were treated with Bindarit, RS504393, and EtOH as described in Fig. 2. 8 h after EtOH treatment, the
expression of TLR4 and its downstream adaptors TRIF and MyD88, and phospho-GSK3βS9 in the brain was determined by IB and quantified by the
normalization to the expression of actin. c SIM-A9 cells were pretreated with TAK242 (1 μM) for 12 h, and then exposed to EtOH (0.4%) for 12 h. The
expression of GSK3β, phospho-GSK3βS9, phospho-GSK3βY216, MCP-1, and CCR2 was by IB and quantified by the normalization to the expression of
actin. d SIM-A9 cells were pretreated SB-216763 (10 μM) for 12 h, and then exposed to EtOH (0.4%) for 12 h. The expression of TLR4, MCP-1, and CCR2
was by IB and quantified by the normalization to the expression of actin. Each data point was the mean ± SEM of three independent experiments.
*p < 0.05, statistically significant difference from control group; #p < 0.05, statistically significant difference from EtOH-treated group

neuroinflammatory diseases, such as multiple sclerosis,
stroke, and Alzheimer’s disease [14–19]. Chronic ethanol
exposure induces MCP-1 expression in adult human and
mice brain [24, 25]. We have recently shown that ethanol stimulated MCP-1/CCR-2 signaling in the spinal
cord of early postnatal mice, and knocking out MCP-1
or CCR2 made mice resistant to ethanol-induced apoptosis of spinal cord neurons [70], indicating the involvement of MCP-1/CCR2 signaling in ethanol-induced
neurodegeneration in the developing spinal cord.
The current study showed that ethanol upregulated
MCP-1 at both mRNA and protein levels but not CCR2
expression in the developing brain. Ethanol stimulation

of MCP-1/CCR2 signaling was confirmed by an upregulation of the downstream effector, MCPIP (Fig. 2).
Disrupting MCP-1/CCR2 signaling by either MCP-1 synthesis inhibitor or CCR2 antagonist made mice less susceptible to ethanol-induced apoptotic cell death, microglial
activation, and the expression of pro-inflammatory factors
(Figs. 3, 4, 5, and 6). Gene deletion of MCP-1 or CCR2 also
offered protection against ethanol-induced neurodegeneration in the developing brain (Fig. 4). It appears that MCP-1
deletion provided better protection than CCR2 deletion
(Fig. 4b). The underlying mechanisms are currently unknown. It is possible that MCP-1 may interact with other
chemokine receptors than CCR2 in microglia. It is reported
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that MCP-1 binds to CCR5 in osteoblastic cells [71].
MCP-1/CCR2 signaling plays an important role in microglial activation and neuroinflammation [8–10, 72]. Therefore, the neuroprotection caused by the disruption of
MCP-1/CCR2 signaling may result from suppression of
microglial activation and neuroinflammation. Using a
neuron/microglia co-culture system, we demonstrated that
the presence of microglial cells indeed exacerbated
ethanol-induced neuronal death; while blocking MCP-1/
CCR2 signaling attenuated enhanced ethanol neurotoxicity
in this neuron/microglia co-culture system (Fig. 7). The result further supported the hypothesis that the activation of
microglia contributed to ethanol neurotoxicity. Although
our findings suggest that MCP-1/CCR2-mediated microglial activation and neuroinflammation is involved in
ethanol neurotoxicity, we could not rule out the possibility
of ethanol directly killing the neurons. In primary neuronal
cultures alone, ethanol also reduced neuronal viability but
to a lesser extent, compared to neuron/microglia
co-cultures (Fig. 7). It is possible that in the brain, ethanol
initially causes neuronal damage, triggering MCP-1/
CCR2-mediated microglial activation and neuroinflammation, which further exacerbates neurodegeneration.
Although MCP-1 and CCR2 are primarily expressed by
microglia in mouse and human brain, they are also
expressed in other cell types in the brain, such as astrocytes and neurons, but to a lesser extent [8, 73, 74]. Therefore, the situation in vivo is complex and it is difficult to
separate the effects of microglia-derived MCP-1 from that
deprived from other cell types unless microglia-specific
MCP-1 or CCR2 knock out mice are available.
TLR4, GSK3β, and p38 MAPK are important regulators of microglial activation and neuroinflammation [44,
52, 54, 75, 76]. Since ethanol had little effect on p38
MAPK in the developing brain [41], we focused on
TLR4 and GSK3β in this study. Indeed, TLR4 and
GSK3β were activated by ethanol and involved in
ethanol-induced microglial activation and upregulation
of proinflammatory cytokines (Figs. 8 and 9). Ethanol activated GSK3β by inducing dephosphorylation of GSK3β
at Ser9 in vitro and in vivo (Fig. 9a, b). This is consistent
with our previous findings that ethanol decreased the
phosphorylation of GSK3β (Ser9) in the developing brain
and cultured neuronal cells [60, 77]. Blocking MCP-1/
CCR2 signaling partially mitigated ethanol-induced dephosphorylation of GSK3β (Ser9), therefore alleviating
ethanol-mediated activation of GSK3β. Similarly, blocking MCP-1/CCR2 signaling effectively inhibited ethanolinduced upregulation of TLR4 in vitro and in vivo
(Fig. 9a, b). These results suggest that MCP-1/CCR2
signaling was involved in ethanol-induced activation of
GSK3β and TLR4.
It appears that there was considerable interaction
among MCP-1/CCR2 signaling, GSK3β, and TLR4 in
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response to ethanol exposure. Blocking TLR4 by
TAK242 alleviated ethanol-induced dephosphorylation
of GSK3β (Ser9) and partially inhibited ethanol-induced
upregulation of MCP-1 (Fig. 9c). On the other hand,
blocking GSK3β also attenuated ethanol-induced upregulation of MCP-1 and TLR4 (Fig. 9d). Based on these
findings, we propose a model to illustrate the cascade of
ethanol-induced microglial activation and neuroinflammation (Fig. 10). In this model, ethanol could directly or
indirectly activate TLR4 and stimulate its downstream
effectors such as TRIF and MyD88; the active TLR4 may
also activate GSK3β which may further stimulate TLR4.
As a result, the activation of TRIF, MyD88, and GSK3β
stimulates transcription factors, such as AP-1 and
NF-κB which upregulate the expression of proinflammatory cytokines and chemokines (e.g., TNF-α, IL6, and
MCP-1). The released MCP-1 interacts with CCR2 and
further activates GSK3β and TLR4; the positive feedback
loop intensifies the neuroinflammation toxic to neurons.
It is also possible that ethanol could directly activate
CCR2 and initiate the downstream signaling cascades.
This possibility is worthy of further investigation.
There are several important implications from this
study. The current finding establishes an important role of
GSK3β in microglial activation and neuroinflammation.
We have previously demonstrated that ethanol-induced
activation of GSK3β in neurons may cause neurodegeneration in the developing brain and in vitro [78]. Our recent
study showed that minocycline inhibited GSK3β and offered protection against ethanol neurotoxicity in the developing brain [41]. Together, these findings suggest that
the activation of GSK3β in both neurons and microglia
contributes to ethanol neurotoxicity, although it may operate by different mechanisms. It further supports that
both neuronal and microglial GSK3β are valid therapeutic
targets for the treatment of ethanol neurotoxicity in the
developing CNS.
In addition to the microglial activation and neuroinflammation, stimulation of MCP-1/CCR2 signaling may
cause neurotoxicity through other mechanisms. For
example, the activation of MCP-1/CCR2 signaling is
reported to cause ER stress through the upregulation of
MCPIP in cardiomyocytes and osteoclasts [79]. Kim et
al. showed that CCR2 inhibitor attenuated ER stress
and decreased the expression of inflammatory cytokines in the liver of type 2 diabetic mice [80]. ER
stress has recently been proposed as an important
mechanism for ethanol-induced damage to the CNS
[25, 81]. Ethanol-induced ER stress in the developing
spinal cord is significantly reduced in MCP-1−/− and
CCR2−/−mice [70]. Therefore, it is also likely that
ethanol-induced upregulation of MCP-1 may cause
ER stress which exacerbates neurodegeneration in the
developing CNS.
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Fig. 10 The interaction among MCP-1/CCR2 signaling, TLR4, and GSK3β in ethanol-induced neuroinflammation. EtOH may stimulate TLR4 and
possibly CCR2, and activate the downstream effectors, such as TRIF and MyD88. Active TLR4 may also activate GSK3β which may further stimulate
TLR4 pathway. As a result, the activation of TRIF, MyD88, and GSK3β stimulates transcription factors which upregulate the expression of proinflammatory
cytokines and chemokines (e.g., TNF-α, IL6, and MCP-1). The released MCP-1 interacts with CCR2 and further activates TLR4 and GSK3β; the positive
feedback loop intensifies the neuroinflammation that is toxic to neurons in the developing CNS

MCP-1/CCR2 signaling has been implicated in AUD.
For example, it is shown that MCP-1/CCR2 signaling
regulates voluntary ethanol consumption. MCP-1 is also
involved in ethanol-induced anxiety-like behavior in
adolescent rats [82]. The current finding along with our
recent study [70] add that MCP-1/CCR2-mediated neuroinflammation and microglial activation contribute to
ethanol neurotoxicity in the developing CNS. Thus,
MCP-1/CCR2 signaling is likely also involved neurological deficits in associated with FASD.

Conclusion
In conclusion, MCP-1/CCR2 signaling played an important
role in ethanol-induced microglial activation/neuroinflammation and neurodegeneration in the developing brain.
The findings offer a potential new therapeutic avenue for
FASD by targeting MCP-1/CCR2 signaling pathway.
Abbreviation
AD: Alzheimer’s disease; AUD: Alcohol use disorders; CCR2: Chemokine (C–C motif)
receptor 2; CNS: Central nervous system; ER: Endoplasmic reticulum; FASD: Fetal
alcohol spectrum disorder; GSK3β: Glycogen synthase kinase 3 beta; Iba-1: Ionized
calcium binding adaptor molecule 1; IFN-γ: Interferon-γ; IHC: Immunohistochemistry;
IL: Interleukin; MCP-1: Monocyte chemoattractant protein-1; PD: Parkinson’s disease;
TLR4: Toll-like receptor 4; TNF-α: Tumor necrosis factor-α

Funding
This research is supported by grants from the National Institutes of Health
(NIH) (AA017226 and AA015407). It is also supported in part by the Department
of Veterans Affairs, Veterans Health Administration, Office of Research and
Development [Biomedical Laboratory Research and Development: Merit Review
(BX001721)].
Availability of data and materials
The authors agree to share all data generated from this study.
Authors’ contributions
KZ performed most experiments in vitro and in vivo, and analyzed/compiled
the data. HW and MX performed qPCR, IHC, and IB analyses in MCP-1−/− and
CCR2−/− mice. KZ and JL contributed to the experimental design and writing
of the manuscript. JAF contributed to writing and editing the manuscript.
All authors read and approved the final manuscript.
Ethics approval
All procedures were performed according to the Institutional Animal Care and
Use Committee (protocol #: 2008-0401).
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.

Zhang et al. Journal of Neuroinflammation (2018) 15:197

Received: 28 February 2018 Accepted: 26 June 2018

References
1. May PA, et al. Prevalence and characteristics of fetal alcohol spectrum
disorders. Pediatrics. 2014;134(5):855–66.
2. Alimov A, et al. Expression of autophagy and UPR genes in the developing
brain during ethanol-sensitive and resistant periods. Metab Brain Dis. 2013;
28(4):667–76.
3. Muralidharan P, et al. Fetal alcohol spectrum disorder (FASD) associated
neural defects: complex mechanisms and potential therapeutic targets.
Brain Sci. 2013;3(2):964–91.
4. Drew PD, Kane CJ. Fetal alcohol spectrum disorders and neuroimmune
changes. Int Rev Neurobiol. 2014;118:41–80.
5. Kane CJ, Phelan KD, Drew PD. Neuroimmune mechanisms in fetal alcohol
spectrum disorder. Dev Neurobiol. 2012;72(10):1302–16.
6. Blanco AM, et al. Ethanol-induced iNOS and COX-2 expression in cultured
astrocytes via NF-kappa B. Neuroreport. 2004;15(4):681–5.
7. Crews FT, et al. Cytokines and alcohol. Alcohol Clin Exp Res. 2006;30(4):720–30.
8. Conductier G, et al. The role of monocyte chemoattractant protein MCP1/CCL2
in neuroinflammatory diseases. J Neuroimmunol. 2010;224(1–2):93–100.
9. Xu LL, et al. Human recombinant monocyte chemotactic protein and other
C-C chemokines bind and induce directional migration of dendritic cells in
vitro. J Leukoc Biol. 1996;60(3):365–71.
10. Carr MW, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte
chemoattractant. Proc Natl Acad Sci U S A. 1994;91(9):3652–6.
11. He J, Crews FT. Increased MCP-1 and microglia in various regions of the
human alcoholic brain. Exp Neurol. 2008;210(2):349–58.
12. Chastain LG, Sarkar DK. Role of microglia in regulation of ethanol neurotoxic
action. Int Rev Neurobiol. 2014;118:81–103.
13. Zhang X, et al. Prenatal alcohol exposure alters the course and severity of
adjuvant-induced arthritis in female rats. Brain Behav Immun. 2012;26(3):439–50.
14. McManus C, et al. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis
lesions: an immunohistochemical and in situ hybridization study. J
Neuroimmunol. 1998;86(1):20–9.
15. Simpson JE, et al. Expression of monocyte chemoattractant protein-1 and
other beta-chemokines by resident glia and inflammatory cells in multiple
sclerosis lesions. J Neuroimmunol. 1998;84(2):238–49.
16. Wang X, Feuerstein GZ. Induced expression of adhesion molecules
following focal brain ischemia. J Neurotrauma. 1995;12(5):825–32.
17. Che X, et al. Monocyte chemoattractant protein-1 expressed in neurons and
astrocytes during focal ischemia in mice. Brain Res. 2001;902(2):171–7.
18. Iarlori C, et al. Expression and production of two selected beta-chemokines
in peripheral blood mononuclear cells from patients with Alzheimer’s
disease. Exp Gerontol. 2005;40(7):605–11.
19. Reale M, et al. The acetylcholinesterase inhibitor, donepezil, regulates a Th2
bias in Alzheimer’s disease patients. Neuropharmacology. 2006;50(5):606–13.
20. Boring L, et al. Impaired monocyte migration and reduced type 1 (Th1)
cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin
Invest. 1997;100(10):2552–61.
21. Kurihara T, et al. Defects in macrophage recruitment and host defense in mice
lacking the CCR2 chemokine receptor. J Exp Med. 1997;186(10):1757–62.
22. Boring L, et al. Decreased lesion formation in CCR2−/− mice reveals a role for
chemokines in the initiation of atherosclerosis. Nature. 1998;394(6696):894–7.
23. Huang D, et al. Chronic expression of monocyte chemoattractant protein-1
in the central nervous system causes delayed encephalopathy and impaired
microglial function in mice. FASEB J. 2005;19(7):761–72.
24. Olney JW, et al. Ethanol-induced apoptotic neurodegeneration in the
developing C57BL/6 mouse brain. Brain Res Dev Brain Res. 2002;133(2):115–26.
25. Ke Z, et al. Ethanol induces endoplasmic reticulum stress in the developing
brain. Alcohol Clin Exp Res. 2011;35(9):1574–83.
26. Urso T, Gavaler JS, Van Thiel DH. Blood ethanol levels in sober alcohol users
seen in an emergency room. Life Sci. 1981;28(9):1053–6.
27. Jones AW. The drunkest drinking driver in Sweden: blood alcohol
concentration 0.545% w/v. J Stud Alcohol. 1999;60(3):400–6.
28. van Hoof JJ, et al. Adolescent alcohol intoxication in the Dutch hospital
departments of pediatrics: a 2-year comparison study. J Adolesc Health.
2011;48(2):212–4.
29. Jones AW, Harding P. Driving under the influence with blood alcohol
concentrations over 0.4 g%. Forensic Sci Int. 2013;231(1–3):349–53.

Page 13 of 14

30. Malejko K, Graf H, Gahr M. Survival of very high blood alcohol concentration
without consequential damage in a patient without a previous substance
use disorder. J Forensic Sci. 2016;61(4):1155–7.
31. Wakida N, et al. CC-chemokine ligand 2 facilitates conditioned place
preference to methamphetamine through the activation of dopamine
systems. J Pharmacol Sci. 2014;125(1):68–73.
32. Zollo M, et al. Targeting monocyte chemotactic protein-1 synthesis with
bindarit induces tumor regression in prostate and breast cancer animal
models. Clin Exp Metastasis. 2012;29(6):585–601.
33. Nagamoto-Combs K, Kulas J, Combs CK. A novel cell line from
spontaneously immortalized murine microglia. J Neurosci Methods. 2014;
233:187–98.
34. Luo J, Miller MW. Differential sensitivity of human neuroblastoma cell lines
to ethanol: correlations with their proliferative responses to mitogenic
growth factors and expression of growth factor receptors. Alcohol Clin Exp
Res. 1997;21(7):1186–94.
35. Paccosi S, et al. The chemokine (C-C motif) ligand protein synthesis inhibitor
bindarit prevents cytoskeletal rearrangement and contraction of human
mesangial cells. Cytokine. 2016;85:92–100.
36. Mirzadegan T, et al. Identification of the binding site for a novel class of CCR2b
chemokine receptor antagonists binding to a common chemokine receptor
motif within the helical bundle. J Biol Chem. 2000;275(33):25562–71.
37. Ho DH, Ring AL, Pollock JS. Early-life stress induces increased plasma Heme
and toll-like receptor 4 activation leading to increased superoxide production
in aortic endothelial cells. FASEB J. 2016;30(1 Supplement):1214.2.
38. Lin S-Y, et al. GSK3-TIP60-ULK1 signaling pathway links growth factor
deprivation to autophagy. Science. 2012;336(6080):477–81.
39. Chen X, et al. Expression and localization of inter-alpha inhibitors in rodent
brain. Neuroscience. 2016;324:69–81.
40. Wang X, et al. Activation of double-stranded RNA-activated protein kinase
by mild impairment of oxidative metabolism in neurons. J Neurochem.
2007;103(6):2380–90.
41. Wang X, et al. Minocycline protects developing brain against ethanolinduced damage. Neuropharmacology. 2018;129:84–99.
42. Wang H, et al. Tunicamycin-induced unfolded protein response in the
developing mouse brain. Toxicol Appl Pharmacol. 2015;283(3):157–67.
43. Chen Z, et al. Lipopolysaccharide-induced microglial activation and
neuroprotection against experimental brain injury is independent of
hematogenous TLR4. J Neurosci. 2012;32(34):11706–15.
44. Wang M-J, et al. Glycogen synthase kinase-3β inactivation inhibits tumor
necrosis factor-α production in microglia by modulating nuclear factor κB
and MLK3/JNK signaling cascades. J Neuroinflammation. 2010;7(1):99.
45. Qin L, et al. Increased systemic and brain cytokine production and
neuroinflammation by endotoxin following ethanol treatment. J
Neuroinflammation. 2008;5:10.
46. Vallieres L, Rivest S. Interleukin-6 is a needed proinflammatory cytokine in
the prolonged neural activity and transcriptional activation of corticotropinreleasing factor during endotoxemia. Endocrinology. 1999;140(9):3890–903.
47. Wang WY, et al. Role of pro-inflammatory cytokines released from microglia
in Alzheimer's disease. Ann Transl Med. 2015;3(10):136.
48. Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the
brain diseases. Curr Med Chem. 2007;14(11):1189–97.
49. Kaur G, et al. Microglia and central nervous system immunity. Neurosurg
Clin N Am. 2010;21(1):43–51.
50. Lucin KM, Wyss-Coray T. Immune activation in brain aging and
neurodegeneration: too much or too little? Neuron. 2009;64(1):110–22.
51. Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol.
2009;40(2):139–56.
52. Yao L, et al. Toll-like receptor 4 mediates microglial activation and
production of inflammatory mediators in neonatal rat brain following
hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflammation. 2013;10:23.
53. Facci L, et al. Toll-like receptors 2, −3 and −4 prime microglia but not
astrocytes across central nervous system regions for ATP-dependent
interleukin-1beta release. Sci Rep. 2014;4:6824.
54. Fernandez-Lizarbe S, Pascual M, Guerri C. Critical role of TLR4 response in the
activation of microglia induced by ethanol. J Immunol. 2009;183(7):4733–44.
55. Yuskaitis CJ, Jope RS. Glycogen synthase kinase-3 regulates microglial
migration, inflammation, and inflammation-induced neurotoxicity. Cell
Signal. 2009;21(2):264–73.
56. Llorens-Martin M, et al. Peripherally triggered and GSK-3beta-driven brain
inflammation differentially skew adult hippocampal neurogenesis,

Zhang et al. Journal of Neuroinflammation (2018) 15:197

57.

58.

59.
60.
61.
62.
63.

64.
65.

66.

67.
68.

69.
70.
71.
72.
73.
74.

75.

76.

77.
78.
79.

80.

81.
82.

behavioral pattern separation and microglial activation in response to
ibuprofen. Transl Psychiatry. 2014;4:e463.
Cortes-Vieyra R, et al. Role of glycogen synthase kinase-3 beta in the
inflammatory response caused by bacterial pathogens. J Inflamm (Lond).
2012;9(1):23.
Li S, et al. MCP-1-induced ERK/GSK-3beta/snail signaling facilitates the
epithelial-mesenchymal transition and promotes the migration of MCF-7
human breast carcinoma cells. Cell Mol Immunol. 2016;14:621–30.
Golpich M, et al. Glycogen synthase kinase-3 beta (GSK-3beta) signaling:
implications for Parkinson's disease. Pharmacol Res. 2015;97:16–26.
Luo J. GSK3beta in ethanol neurotoxicity. Mol Neurobiol. 2009;40(2):108–21.
Maixner DW, Weng HR. The role of glycogen synthase kinase 3 beta in
neuroinflammation and pain. J Pharm Pharmacol (Los Angel). 2013;1(1):001.
Medina M, Wandosell F. Deconstructing GSK-3: the fine regulation of its
activity. Int J Alzheimers Dis. 2011;2011:479249.
Goodlett CR, Horn KH, Zhou FC. Alcohol teratogenesis: mechanisms of
damage and strategies for intervention. Exp Biol Med (Maywood). 2005;
230(6):394–406.
Chen G, Luo J. Anthocyanins: are they beneficial in treating ethanol
neurotoxicity? Neurotox Res. 2010;17(1):91–101.
Boyadjieva NI, Sarkar DK. Cyclic adenosine monophosphate and brainderived neurotrophic factor decreased oxidative stress and apoptosis in
developing hypothalamic neuronal cells: role of microglia. Alcohol Clin Exp
Res. 2013;37(8):1370–9.
Kane CJ, Drew PD. Inflammatory responses to alcohol in the CNS: nuclear
receptors as potential therapeutics for alcohol-induced neuropathologies. J
Leukoc Biol. 2016;100(5):951–9.
Crews FT, et al. The role of neuroimmune signaling in alcoholism.
Neuropharmacology. 2017;122:56–73.
Saito M, et al. Ethanol-induced neurodegeneration and glial activation in
the developing brain. Brain Sci. 2016;6(3) https://doi.org/10.3390/
brainsci6030031.
Wilhelm CJ, Guizzetti M. Fetal alcohol spectrum disorders: an overview from
the glia perspective. Front Integr Neurosci. 2015;9:65.
Ren Z, et al. Ethanol-induced damage to the developing spinal cord: the
involvement of CCR2 signaling. Biochim Biophys Acta. 2017;1863(11):2746–61.
Craig MJ, Loberg RD. CCL2 (monocyte chemoattractant protein-1) in cancer
bone metastases. Cancer Metastasis Rev. 2006;25(4):611–9.
Selenica M-LB, et al. Diverse activation of microglia by chemokine (CC
motif) ligand 2 overexpression in brain. J Neuroinflammation. 2013;10(1):856.
Stowe AM, et al. CCL2 upregulation triggers hypoxic preconditioninginduced protection from stroke. J Neuroinflammation. 2012;9(1):33.
Howe CL, et al. Neuronal CCL2 expression drives inflammatory monocyte
infiltration into the brain during acute virus infection. J Neuroinflammation.
2017;14(1):238.
Badshah H, et al. Protective effect of lupeol against lipopolysaccharideinduced neuroinflammation via the p38/c-Jun N-terminal kinase pathway in
the adult mouse brain. J NeuroImmune Pharmacol. 2016;11(1):48–60.
Papageorgiou IE, et al. TLR4-activated microglia require IFN-gamma to
induce severe neuronal dysfunction and death in situ. Proc Natl Acad Sci U
S A. 2016;113(1):212–7.
Luo J. The role of GSK3beta in the development of the central nervous
system. Front Biol (Beijing). 2012;7(3):212–20.
Liu Y, et al. Overexpression of glycogen synthase kinase 3beta sensitizes
neuronal cells to ethanol toxicity. J Neurosci Res. 2009;87(12):2793–802.
Roy A, Kolattukudy PE. Monocyte chemotactic protein-induced protein
(MCPIP) promotes inflammatory angiogenesis via sequential induction of
oxidative stress, endoplasmic reticulum stress and autophagy. Cell Signal.
2012;24(11):2123–31.
Kim H-M, et al. CC chemokine receptor 2 inhibitor ameliorates hepatic
steatosis by improving ER stress and inflammation in a type 2 diabetic
mouse model. PLoS One. 2015;10(3):e0120711.
Yang F, Luo J. Endoplasmic reticulum stress and ethanol neurotoxicity.
Biomolecules. 2015;5(4):2538–53.
Harper KM, et al. Age-related differences in anxiety-like behavior and
amygdalar CCL2 responsiveness to stress following alcohol withdrawal in
male Wistar rats. Psychopharmacology. 2017;234(1):79–88.

Page 14 of 14

